Replimune Group, Inc. (REPL) Key Metrics
REPL valuation today
Trailing 12 months · as of October 17, 2026- Market cap
- $1.02B
- Enterprise value
- $1.14B
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 11.6 10-yr median 2.0
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.94
REPL key metrics, FY2017–FY2026
Fiscal year ended March 31, 2026 · U.S. dollarsREPL valuation Price multiples at each fiscal year-end price.
REPL returns How much profit the business earns on the capital it uses.
REPL per-share figures Results divided by the shares outstanding at year-end.
REPL financial health Debt, liquidity and how easily interest is covered.
REPL valuation history
REPL returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
REPL debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
REPL cash returned to shareholders
REPL price vs earnings per share
REPL key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $709.9M | $785.5M | $543.9M | $1.03B | $886.6M | $1.41B | $341.6M | $353.1M | — | — |
| Enterprise value | $552.6M | $377.9M | $199.1M | $505.4M | $523.7M | $968.0M | $214.8M | $224.8M | — | — |
| Price / book | 4.3 | 1.9 | 1.5 | 1.9 | 2.2 | 2.8 | 1.9 | 2.6 | — | — |
| Earnings yield | −44.2% | −31.5% | −39.7% | −17.0% | −13.3% | −5.7% | −15.4% | −8.7% | — | — |
| Free cash flow yield | −40.1% | −25.3% | −35.1% | −12.7% | −9.5% | −4.5% | −19.6% | −7.9% | — | — |
| Dividend yield | — | — | — | — | — | 6.5% | 8.2% | — | — | — |
| Shareholder yield (dividends + buybacks) | — | — | — | 0.0% | — | 6.5% | 8.2% | 0.0% | — | — |
| Share price at fiscal year-end | $7.65 | $9.75 | $8.17 | $17.66 | $16.98 | $30.51 | $9.97 | $15.22 | — | — |
| Per share | ||||||||||
| Revenue per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings per share | −$3.38 | −$3.07 | −$3.24 | −$2.99 | −$2.26 | −$1.75 | −$1.54 | −$1.33 | −$0.64 | −$0.25 |
| Operating cash flow per share | −$3.02 | −$2.39 | −$2.79 | −$2.20 | −$1.57 | −$1.33 | −$1.77 | −$1.09 | −$0.52 | −$0.23 |
| Free cash flow per share | −$3.07 | −$2.47 | −$2.87 | −$2.24 | −$1.62 | −$1.38 | −$1.96 | −$1.21 | −$0.52 | −$0.24 |
| Cash per share | $2.90 | $6.01 | $6.32 | $10.02 | $7.58 | $10.30 | $4.92 | $5.81 | $2.00 | $0.67 |
| Book value per share | $1.79 | $5.16 | $5.63 | $9.54 | $7.88 | $10.78 | $5.36 | $5.94 | −$0.91 | −$0.37 |
| Tangible book value per share | $1.79 | $5.16 | $5.63 | $9.54 | $7.88 | $10.78 | $5.36 | $5.94 | −$0.91 | −$0.37 |
| Dividends per share | — | — | — | — | — | $1.98 | $0.82 | — | — | — |
| Capex per share | $0.05 | $0.08 | $0.09 | $0.04 | $0.04 | $0.05 | $0.19 | $0.11 | $0.00 | $0.01 |
| Debt per share | $1.20 | $0.95 | $1.14 | $1.04 | $0.63 | $0.72 | $1.22 | $0.28 | — | — |
| Shares outstanding | 92.8M | 80.6M | 66.6M | 58.2M | 52.2M | 46.2M | 34.3M | 23.2M | 30.8M | 30.8M |
| Change in shares outstanding | +15.2% | +21.0% | +14.4% | +11.5% | +12.9% | +35.0% | +47.7% | −24.8% | 0.0% | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −107.9% | −62.6% | −46.4% | −36.1% | −25.9% | −23.7% | −32.7% | −56.2% | — | — |
| Return on invested capital (ROIC) | — | — | −594.7% | −345.1% | −184.4% | −116.1% | −133.4% | — | — | — |
| Return on assets (ROA) | −71.0% | −47.6% | −38.0% | −31.5% | −23.5% | −20.8% | −27.1% | −28.1% | −44.8% | −33.8% |
| Return on tangible assets | −94.4% | −44.9% | −44.2% | −27.0% | −25.6% | −14.9% | −22.5% | −20.0% | −30.2% | −33.8% |
| Financial health | ||||||||||
| Total debt | $111.6M | $76.2M | $75.9M | $60.8M | $32.8M | $33.3M | $41.8M | $6.6M | — | — |
| Cash & short-term investments | $268.9M | $483.8M | $420.7M | $583.4M | $395.7M | $476.3M | $168.6M | $134.8M | $61.6M | $20.6M |
| Net debt | −$157.3M | −$407.6M | −$344.8M | −$522.6M | −$362.8M | −$443.0M | −$126.8M | −$128.2M | −$61.6M | −$20.6M |
| Debt / equity | 0.67 | 0.18 | 0.20 | 0.11 | 0.08 | 0.07 | 0.23 | 0.05 | — | — |
| Debt / assets | 0.34 | 0.14 | 0.16 | 0.09 | 0.07 | 0.06 | 0.18 | 0.04 | — | — |
| Current ratio | 4.79 | 7.95 | 10.72 | 17.52 | 19.46 | 33.25 | 14.68 | 14.26 | 12.53 | 11.29 |
| Quick ratio | 4.79 | 7.95 | 10.72 | 17.52 | 19.46 | 33.46 | 14.92 | 14.26 | 12.53 | 11.29 |
| Interest coverage | -36.1 | -33.1 | -35.3 | -42.6 | -54.6 | -27.0 | -29.3 | — | — | — |
| Working capital | $220.9M | $433.5M | $393.2M | $558.8M | $383.2M | $469.2M | $162.4M | $131.1M | $59.5M | $20.4M |
| Invested capital | $8.9M | $8.2M | $29.7M | $32.7M | $48.4M | $55.7M | $57.0M | $9.6M | −$89.6M | −$32.1M |
| Tangible asset value | $166.2M | $415.8M | $374.5M | $555.3M | $411.2M | $498.7M | $183.7M | $137.9M | −$28.1M | −$11.5M |
| Net current asset value | $112.9M | $360.4M | $320.5M | $501.3M | $354.0M | $439.4M | $123.9M | $124.5M | −$28.5M | −$11.9M |
| Graham net-net per share | $1.12 | $4.36 | $4.67 | $8.49 | $6.66 | $9.36 | $3.47 | $5.18 | −$0.97 | −$0.41 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | $91.7M | $28.1M | — | — | — |
| Share buybacks (net) | — | — | — | $0 | — | $0 | $0 | $0 | $0 | $0 |
| Capex / depreciation | 1.27 | 1.91 | 2.13 | 0.93 | 1.09 | 1.40 | 12.27 | 17.57 | 1.25 | 1.95 |
| Efficiency | ||||||||||
| Days of inventory on hand | — | — | — | — | — | -260.8 | -598.3 | — | — | — |
| Days payables outstanding | — | 783.8 | 545.9 | 678.4 | 242.8 | 255.3 | 1,062.3 | 11,192.9 | 3,877.7 | 966.4 |
| Receivables turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables turnover | — | 0.47 | 0.67 | 0.54 | 1.50 | 1.43 | 0.34 | 0.03 | 0.09 | 0.38 |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | $2.7M | $4.3M | $3.9M | $3.0M | $3.0M | $3.0M | $2.7M | $2.4M | $1.9M | $1.4M |
| Average payables | $9.6M | $7.5M | $4.0M | $4.5M | $3.0M | $2.9M | $5.3M | $4.5M | $1.2M | $323,000 |
| Average inventory | — | — | — | — | — | −$3.0M | −$3.0M | — | — | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from REPL's annual financial statements (latest annual report filed June 29, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
REPL valuation and financial ratios
Replimune earned a return on equity of −107.9% in fiscal 2026. It ended the year with $111.6 million of debt and $268.9 million in cash and short-term investments, a net cash position of $157.3 million. The share count rose 200.9% from 30.8M to 92.8M over 9 years.
See the REPL income statement, the REPL chart for price history, or the REPL stock overview for the latest quote and news.
REPL key metrics FAQ
What is Replimune's return on equity?
Replimune's return on equity (ROE) was −107.9% in fiscal 2026: net income of -$313.9 million on average shareholders' equity of $291.0 million.
How much debt does Replimune have?
Replimune had total debt of $111.6 million at the end of fiscal 2026, a debt-to-equity ratio of 0.67 and more cash than debt.
What is Replimune's free cash flow yield?
Replimune generated -$284.6 million of free cash flow in fiscal 2026, a free cash flow yield of −40.1% on its market value at year-end ($709.9 million).
What is Replimune's current ratio?
Replimune's current ratio was 4.79 at the end of fiscal 2026: current assets were 4.79 times current liabilities.